Discover 152 paid clinical trials in Portland, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 152
Active & Responsive
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
for
Mitral Valve Regurgitation
Location: Portland ME, Boston MA, Lebanon NH, Quebec, New York NY, Ottawa,
Sponsor: Annetine Gelijns
Sex: All
Age: 60+
Code: NCT05051033
Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Augusta ME, Methuen MA, Boston MA, Weymouth MA, Brewer ME,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation
for
Atrial Fibrillation Paroxysmal
Location: Portland ME, Burlington MA, Boston MA, Manhasset NY,
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 21 - 70+
Code: NCT06364215
Recruiting
Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy
Location: Portland ME, Roanoke VA, Lexington KY, Sioux Falls SD,
Sponsor: University of Kentucky
Sex: All
Age: 50 - 70+
Code: NCT06164587
Phase1, Phase2, Recruiting
Lung Transplant READY CF 2: A Multi-site RCT
for
Cystic Fibrosis
Location: Portland ME, New Haven CT, Baltimore MD, Pittsburgh PA,
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06030206
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy